80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis cash on hand 1998–2026What is a balance sheet? The balance sheet lists what a company owns (assets), what it owes (liabilities) and what is left for its shareholders (equity) on one date.
Novartis had 8.98B USD in cash and short-term investments on 30 September 2026, down 8.0% on a year before. At the end of fiscal year 2025 it had 11.59B USD.
Last updated 8 Nov 2026 · Next report 3 Feb 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 8.98B | -7.98% | 48.31B | -39.34B |
| FY2025 | 31 Dec 2025 | 11.59B | -13.19% | 35.38B | -23.79B |
| FY2024 | 31 Dec 2024 | 13.35B | -4.38% | 31.26B | -17.91B |
| FY2023 | 31 Dec 2023 | 13.96B | -25.00% | 26.35B | -12.39B |
| FY2022 | 31 Dec 2022 | 18.62B | -33.79% | 27.91B | -9.29B |
| FY2021 | 31 Dec 2021 | 28.11B | +143.13% | 31.03B | -2.91B |
| FY2020 | 31 Dec 2020 | 11.56B | +1.02% | 37.86B | -26.29B |
| FY2019 | 31 Dec 2019 | 11.45B | -28.30% | 29.15B | -17.70B |
| FY2018 | 31 Dec 2018 | 15.96B | +68.31% | 32.09B | -16.13B |
| FY2017 | 31 Dec 2017 | 9.49B | +21.96% | 28.43B | -18.94B |
| FY2016 | 31 Dec 2016 | 7.78B | +42.78% | 23.80B | -16.03B |
| FY2015 | 31 Dec 2015 | 5.45B | -60.71% | 21.93B | -16.48B |
| FY2014 | 31 Dec 2014 | 13.86B | +50.31% | 20.41B | -6.55B |
| FY2013 | 31 Dec 2013 | 9.22B | +13.59% | 18.02B | -8.80B |
| FY2012 | 31 Dec 2012 | 8.12B | +59.98% | 19.73B | -11.61B |
| FY2011 | 31 Dec 2011 | 5.08B | -37.61% | 20.20B | -15.12B |
| FY2010 | 31 Dec 2010 | 8.13B | -53.38% | 22.94B | -14.81B |
| FY2009 | 31 Dec 2009 | 17.45B | +185.25% | 13.91B | 3.54B |
| FY2008 | 31 Dec 2008 | 6.12B | -53.66% | 7.04B | -918.00M |
| FY2007 | 31 Dec 2007 | 13.20B | +65.95% | 5.59B | 7.61B |
| FY2006 | 31 Dec 2006 | 7.96B | -27.24% | 7.22B | 739.00M |
| FY2005 | 31 Dec 2005 | 10.93B | -25.08% | 8.21B | 2.72B |
| FY2004 | 31 Dec 2004 | 14.59B | +10.06% | 6.56B | 8.04B |
| FY2003 | 31 Dec 2003 | 13.26B | +5.44% | 5.47B | 7.79B |
| FY2002 | 31 Dec 2002 | 12.58B | -4.61% | 5.59B | 6.99B |
| FY2001 | 31 Dec 2001 | 13.18B | +5.35% | 4.57B | 8.62B |
| FY2000 | 31 Dec 2000 | 12.51B | +21.86% | 3.70B | 8.82B |
| FY1999 | 31 Dec 1999 | 10.27B | +5.95% | 6.24B | 4.03B |
| FY1998 | 31 Dec 1998 | 9.69B | — | 6.24B | 3.46B |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 8.98B | -7.98% | 48.31B | -39.34B |
| Q2 FY2026 | 30 Jun 2026 | 7.69B | +9.86% | 49.01B | -41.32B |
| Q1 FY2026 | 31 Mar 2026 | 6.98B | -3.04% | 47.00B | -40.02B |
| Q4 FY2025 | 31 Dec 2025 | 11.59B | -13.19% | 37.11B | -25.52B |
| Q3 FY2025 | 29 Sept 2025 | 9.75B | -30.44% | 32.02B | -22.27B |
| Q2 FY2025 | 30 Jun 2025 | 7.00B | -17.01% | 32.64B | -25.64B |
| Q1 FY2025 | 31 Mar 2025 | 7.20B | -25.77% | 31.27B | -24.07B |
| Q4 FY2024 | 31 Dec 2024 | 13.35B | -7.46% | 31.26B | -17.91B |
| Q3 FY2024 | 30 Sept 2024 | 14.02B | +10.44% | 32.16B | -18.14B |
| Q2 FY2024 | 30 Jun 2024 | 8.44B | -24.51% | 28.99B | -20.55B |
| Q1 FY2024 | 31 Mar 2024 | 9.69B | -20.93% | 27.28B | -17.59B |
| Q4 FY2023 | 31 Dec 2023 | 14.43B | -23.78% | 26.35B | -11.92B |
| Q3 FY2023 | 30 Sept 2023 | 12.70B | -33.54% | 25.19B | -12.49B |
| Q2 FY2023 | 30 Jun 2023 | 11.17B | -43.45% | 28.34B | -17.17B |
| Q1 FY2023 | 31 Mar 2023 | 12.26B | -34.84% | 29.20B | -16.94B |
| Q4 FY2022 | 31 Dec 2022 | 18.93B | -33.18% | 27.91B | -8.98B |
| Q3 FY2022 | 30 Sept 2022 | 19.10B | +134.05% | 28.54B | -9.44B |
| Q2 FY2022 | 30 Jun 2022 | 19.76B | +268.89% | 31.09B | -11.33B |
| Q1 FY2022 | 31 Mar 2022 | 18.81B | +361.47% | 31.34B | -12.53B |
| Q4 FY2021 | 31 Dec 2021 | 28.33B | +145.00% | 31.03B | -2.70B |
| Q3 FY2021 | 30 Sept 2021 | 8.16B | -24.91% | 34.33B | -26.17B |
| Q2 FY2021 | 30 Jun 2021 | 5.36B | -14.89% | 35.85B | -30.49B |
| Q1 FY2021 | 31 Mar 2021 | 4.08B | -18.02% | 37.84B | -33.77B |
| Q4 FY2020 | 31 Dec 2020 | 11.56B | +1.02% | 37.86B | -26.29B |
| Q3 FY2020 | 30 Sept 2020 | 10.87B | +24.70% | 38.18B | -27.31B |
| Q2 FY2020 | 30 Jun 2020 | 6.29B | -39.11% | 34.79B | -28.49B |
| Q1 FY2020 | 31 Mar 2020 | 4.97B | -30.08% | 36.70B | -31.72B |
| Q4 FY2019 | 31 Dec 2019 | 11.45B | -28.30% | 29.15B | -17.70B |
| Q3 FY2019 | 30 Sept 2019 | 8.72B | -40.74% | 30.12B | -21.40B |
| Q2 FY2019 | 30 Jun 2019 | 10.34B | -21.38% | 30.27B | -19.93B |
| Q1 FY2019 | 31 Mar 2019 | 7.11B | +10.74% | 30.59B | -23.48B |
| Q4 FY2018 | 31 Dec 2018 | 15.96B | +68.31% | 32.09B | -16.13B |
| Q3 FY2018 | 30 Sept 2018 | 14.71B | +56.51% | 31.78B | -17.07B |
| Q2 FY2018 | 30 Jun 2018 | 13.15B | +56.11% | 32.36B | -19.21B |
| Q1 FY2018 | 31 Mar 2018 | 6.42B | -22.03% | 34.11B | -27.69B |
| Q4 FY2017 | 31 Dec 2017 | 9.49B | +21.96% | 28.43B | -18.94B |
| Q3 FY2017 | 30 Sept 2017 | 9.40B | +21.45% | 30.16B | -20.76B |
| Q2 FY2017 | 30 Jun 2017 | 8.42B | +49.10% | 30.56B | -22.14B |
| Q1 FY2017 | 31 Mar 2017 | 8.24B | +62.47% | 31.26B | -23.02B |
| Q4 FY2016 | 31 Dec 2016 | 7.78B | +42.78% | 23.80B | -16.03B |
| Q3 FY2016 | 30 Sept 2016 | 7.74B | +30.46% | 26.57B | -18.83B |
| Q2 FY2016 | 30 Jun 2016 | 5.65B | -2.79% | 26.37B | -20.72B |
| Q1 FY2016 | 31 Mar 2016 | 5.07B | -31.14% | 28.09B | -23.02B |
| Q4 FY2015 | 31 Dec 2015 | 5.45B | -60.71% | 21.93B | -16.48B |
| Q3 FY2015 | 30 Sept 2015 | 5.93B | -43.11% | 22.70B | -16.77B |
| Q2 FY2015 | 30 Jun 2015 | 5.81B | -20.60% | 23.27B | -17.46B |
| Q1 FY2015 | 31 Mar 2015 | 7.36B | -4.64% | 25.11B | -17.75B |
| Q4 FY2014 | 31 Dec 2014 | 13.86B | +50.31% | 20.41B | -6.55B |
| Q3 FY2014 | 30 Sept 2014 | 10.43B | +43.43% | 19.61B | -9.18B |
| Q2 FY2014 | 30 Jun 2014 | 7.32B | +43.72% | 20.43B | -13.11B |
| Q1 FY2014 | 31 Mar 2014 | 7.72B | +27.94% | 21.21B | -13.49B |
| Q4 FY2013 | 31 Dec 2013 | 9.22B | +13.59% | 18.02B | -8.80B |
| Q3 FY2013 | 30 Sept 2013 | 7.27B | — | 18.78B | -11.51B |
| Q2 FY2013 | 30 Jun 2013 | 5.09B | — | 18.87B | -13.78B |
| Q1 FY2013 | 31 Mar 2013 | 6.04B | — | 20.94B | -14.91B |
| Q4 FY2012 | 31 Dec 2012 | 8.12B | +59.98% | 19.73B | -11.61B |
| Q3 FY2012 | 30 Sept 2012 | 0.00 | — | 20.84B | -20.84B |
| Q2 FY2012 | 30 Jun 2012 | 0.00 | — | 22.63B | -22.63B |
| Q1 FY2012 | 31 Mar 2012 | 0.00 | — | 24.59B | -24.59B |
| Q4 FY2011 | 31 Dec 2011 | 5.08B | -37.61% | 20.20B | -15.12B |
| Q3 FY2011 | 30 Sept 2011 | 0.00 | — | 23.89B | -23.89B |
| Q2 FY2011 | 30 Jun 2011 | 0.00 | — | 27.51B | -27.51B |
| Q1 FY2011 | 31 Mar 2011 | 0.00 | — | 31.11B | -31.11B |
| Q4 FY2010 | 31 Dec 2010 | 8.13B | -53.38% | 22.94B | -14.81B |
| Q3 FY2010 | 30 Sept 2010 | 0.00 | — | 26.96B | -26.96B |
| Q2 FY2010 | 30 Jun 2010 | 0.00 | — | 18.64B | -18.64B |
| Q1 FY2010 | 31 Mar 2010 | 0.00 | — | 17.93B | -17.93B |
| Q4 FY2009 | 31 Dec 2009 | 17.45B | +185.25% | 13.91B | 3.54B |
| Q3 FY2009 | 30 Sept 2009 | 0.00 | -100.00% | 14.37B | -14.37B |
| Q2 FY2009 | 30 Jun 2009 | 0.00 | -100.00% | 13.87B | -13.87B |
| Q1 FY2009 | 31 Mar 2009 | 0.00 | -100.00% | 11.45B | -11.45B |
| Q4 FY2008 | 31 Dec 2008 | 6.12B | -53.66% | 7.04B | -918.00M |
| Q3 FY2008 | 30 Sept 2008 | 8.14B | -44.01% | 10.80B | -2.67B |
| Q2 FY2008 | 30 Jun 2008 | 16.20B | +114.60% | 10.73B | 5.47B |
| Q1 FY2008 | 31 Mar 2008 | 10.85B | +55.96% | 6.48B | 4.37B |
| Q4 FY2007 | 31 Dec 2007 | 13.20B | +65.95% | 5.59B | 7.61B |
| Q3 FY2007 | 30 Sept 2007 | 14.53B | +70.36% | 7.24B | 7.29B |
| Q2 FY2007 | 30 Jun 2007 | 7.55B | +3.26% | 7.45B | 97.00M |
| Q1 FY2007 | 31 Mar 2007 | 6.96B | -37.42% | 7.35B | -393.00M |
| Q4 FY2006 | 31 Dec 2006 | 7.96B | -27.24% | 7.22B | 739.00M |
| Q3 FY2006 | 30 Sept 2006 | 8.53B | +7.34% | 9.22B | -691.00M |
| Q2 FY2006 | 30 Jun 2006 | 7.31B | -22.56% | 9.43B | -2.12B |
| Q1 FY2006 | 31 Mar 2006 | 11.12B | -9.49% | 8.09B | 3.02B |
| Q4 FY2005 | 31 Dec 2005 | 10.93B | -25.08% | 8.21B | 2.72B |
| Q3 FY2005 | 30 Sept 2005 | 7.95B | -34.78% | 6.90B | 1.05B |
| Q2 FY2005 | 30 Jun 2005 | 9.44B | -23.26% | 7.69B | 1.75B |
| Q1 FY2005 | 31 Mar 2005 | 12.28B | +1.45% | 6.05B | 6.24B |
| Q4 FY2004 | 31 Dec 2004 | 14.59B | +10.06% | 6.56B | 8.04B |
| Q3 FY2004 | 30 Sept 2004 | 12.19B | +2.82% | 5.53B | 6.65B |
| Q2 FY2004 | 30 Jun 2004 | 12.30B | +10.45% | 5.99B | 6.31B |
| Q1 FY2004 | 31 Mar 2004 | 12.11B | -6.13% | 6.54B | 5.56B |
| Q4 FY2003 | 31 Dec 2003 | 13.26B | +5.44% | 5.47B | 7.79B |
| Q3 FY2003 | 30 Sept 2003 | 11.85B | +14.71% | 5.62B | 6.23B |
| Q2 FY2003 | 30 Jun 2003 | 11.14B | -13.70% | 6.97B | 4.17B |
| Q1 FY2003 | 31 Mar 2003 | 12.90B | — | 5.88B | 7.02B |
| Q4 FY2002 | 31 Dec 2002 | 12.58B | -4.61% | 5.59B | 6.99B |
| Q3 FY2002 | 30 Sept 2002 | 10.33B | — | 4.92B | 5.42B |
| Q2 FY2002 | 30 Jun 2002 | 12.91B | +53.54% | 5.05B | 7.86B |
| Q4 FY2001 | 31 Dec 2001 | 13.18B | +5.35% | 4.57B | 8.62B |
| Q2 FY2001 | 30 Jun 2001 | 8.41B | -35.04% | 4.33B | 4.08B |
| Q4 FY2000 | 31 Dec 2000 | 12.51B | — | 3.70B | 8.82B |
| Q2 FY2000 | 30 Jun 2000 | 12.94B | — | 5.09B | 7.85B |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about Novartis's cash
Source: Financial Modeling Prep